We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Masimo (MASI) Gets CE Mark for Respiration Sensor RAS-45
Read MoreHide Full Article
Masimo Corporation (MASI - Free Report) recently announced the receipt of CE mark for RAS-45, a single use adhesive respiration sensor for ‘rainbow acoustic monitoring’ of respiration rate. This approval is expected to strengthen the company’s foothold in growing respiratory care market in Europe.
Notably, rainbow acoustic monitoring or RAM is a flagship noninvasive technology of Masimo that continuously measures respiration rate of the prospective patients using an adhesive sensor and an acoustic transducer.
RAS-45 exclusively operates for post-surgical patients undergoing patient-controlled analgesia (self administered pain management). Here we note that RAS-45 and RAS 125-c are two notable adhesive sensors in RAM.
As per management, the RAS-45 go-ahead highlights the exclusivity of the product (smaller adhesive profile, usage of transparent adhesive and flexibility) compared to the likes that are presently available in the market. The product is also likely to empower the company’s flagship signal extraction (SET), rainbow and the MX technologies.
We believe that the latest development will significantly fortify the company’s product portfolio of adhesive sensors and thus help the company tap into the abundant opportunities in Europe. Meanwhile, Masimo’s SET pulse oximetry business already represents considerable growth opportunities in international markets.
Even the global market trends seem to be quite lucrative as an analysis by the Markets And Markets reveal that the respiratory-care devices market is forecasted to grow at a CAGR of 9.6% to $21.9 billion by 2020. Buoyed by this trend, we presume Masimo with its series of latest product developments, will significantly gain traction in the respiratory care and related ancillary markets .
Lately shares of Masimo have been on the rise with a strong one-year return of 38.8%, much better than the S&P 500’s 7.4% over the same period. We believe, the CE mark for RAS-45 will help the company maintain the trend.
Zacks Rank & Other Key Picks
Currently, Masimo has a Zacks Rank #1 (Strong Buy).
Other favorably ranked stocks in the broader medical sector include CryoLife Inc. , Natus Medical and NuVasive Inc. . Notably, all the three stocks sport the same Zacks Rank as Masimo.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Masimo (MASI) Gets CE Mark for Respiration Sensor RAS-45
Masimo Corporation (MASI - Free Report) recently announced the receipt of CE mark for RAS-45, a single use adhesive respiration sensor for ‘rainbow acoustic monitoring’ of respiration rate. This approval is expected to strengthen the company’s foothold in growing respiratory care market in Europe.
Notably, rainbow acoustic monitoring or RAM is a flagship noninvasive technology of Masimo that continuously measures respiration rate of the prospective patients using an adhesive sensor and an acoustic transducer.
RAS-45 exclusively operates for post-surgical patients undergoing patient-controlled analgesia (self administered pain management). Here we note that RAS-45 and RAS 125-c are two notable adhesive sensors in RAM.
As per management, the RAS-45 go-ahead highlights the exclusivity of the product (smaller adhesive profile, usage of transparent adhesive and flexibility) compared to the likes that are presently available in the market. The product is also likely to empower the company’s flagship signal extraction (SET), rainbow and the MX technologies.
MASIMO CORP Price
MASIMO CORP Price | MASIMO CORP Quote
Our Take
We believe that the latest development will significantly fortify the company’s product portfolio of adhesive sensors and thus help the company tap into the abundant opportunities in Europe. Meanwhile, Masimo’s SET pulse oximetry business already represents considerable growth opportunities in international markets.
Even the global market trends seem to be quite lucrative as an analysis by the Markets And Markets reveal that the respiratory-care devices market is forecasted to grow at a CAGR of 9.6% to $21.9 billion by 2020. Buoyed by this trend, we presume Masimo with its series of latest product developments, will significantly gain traction in the respiratory care and related ancillary markets .
Lately shares of Masimo have been on the rise with a strong one-year return of 38.8%, much better than the S&P 500’s 7.4% over the same period. We believe, the CE mark for RAS-45 will help the company maintain the trend.
Zacks Rank & Other Key Picks
Currently, Masimo has a Zacks Rank #1 (Strong Buy).
Other favorably ranked stocks in the broader medical sector include CryoLife Inc. , Natus Medical and NuVasive Inc. . Notably, all the three stocks sport the same Zacks Rank as Masimo.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>